These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22696642)

  • 1. Antiretroviral agents effectively block HIV replication after cell-to-cell transfer.
    Permanyer M; Ballana E; Ruiz A; Badia R; Riveira-Munoz E; Gonzalo E; Clotet B; Esté JA
    J Virol; 2012 Aug; 86(16):8773-80. PubMed ID: 22696642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT.
    Biswas DK; Mhashilkar AM; Ewaniuk DS; Pezza JA; Oh LM; Kannangara GS; Tius MA; Pardee AB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):426-34. PubMed ID: 9715838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission.
    Van Herrewege Y; Penne L; Vereecken C; Fransen K; van der Groen G; Kestens L; Balzarini J; Vanham G
    AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1091-102. PubMed ID: 12396448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression.
    Missé D; Gajardo J; Oblet C; Religa A; Riquet N; Mathieu D; Yssel H; Veas F
    AIDS; 2005 Jun; 19(9):897-905. PubMed ID: 15905670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy.
    Sigal A; Kim JT; Balazs AB; Dekel E; Mayo A; Milo R; Baltimore D
    Nature; 2011 Aug; 477(7362):95-8. PubMed ID: 21849975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro post-integration latency models.
    Bonczkowski P; De Scheerder MA; Malatinkova E; Borch A; Melkova Z; Koenig R; De Spiegelaere W; Vandekerckhove L
    Sci Rep; 2016 Dec; 6():38329. PubMed ID: 27910923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination antiretroviral therapy and cell-cell spread of wild-type and drug-resistant human immunodeficiency virus-1.
    Titanji BK; Pillay D; Jolly C
    J Gen Virol; 2017 Apr; 98(4):821-834. PubMed ID: 28141491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4+ T cells limits antiretroviral efficacy.
    Duncan CJ; Russell RA; Sattentau QJ
    AIDS; 2013 Sep; 27(14):2201-6. PubMed ID: 24005480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-incubation of cell-free HIV-1 group M isolates with non-nucleoside reverse transcriptase inhibitors blocks subsequent viral replication in co-cultures of dendritic cells and T cells.
    Njai HF; Lewi PJ; Janssen CG; Garcia S; Fransen K; Kestens L; Vanham G; Janssen PA
    Antivir Ther; 2005; 10(2):255-62. PubMed ID: 15865220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
    Kashanchi F; Sadaie MR; Brady JN
    Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events.
    Lucera MB; Tilton CA; Mao H; Dobrowolski C; Tabler CO; Haqqani AA; Karn J; Tilton JC
    J Virol; 2014 Sep; 88(18):10803-12. PubMed ID: 25008921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type 1 replication in monocytoid and placental Hofbauer cells: implications for the prevention of maternal-fetal transmission of HIV.
    Lee AW; Mitra D; Laurence J
    AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1235-42. PubMed ID: 9310291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: relative effect of recombinant CD4, zidovudine, and saquinavir in vitro.
    Panther LA; Coombs RW; Aung SA; dela Rosa C; Gretch D; Corey L
    J Med Virol; 1999 Jun; 58(2):165-73. PubMed ID: 10335865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of HIV-1 and Human T Cell Lymphotropic Virus Type 1 Replication-Dependent Vectors via Optimization of Reporter Gene Reconstitution and Modification with Intronic Short Hairpin RNA.
    Shunaeva A; Potashnikova D; Pichugin A; Mishina A; Filatov A; Nikolaitchik O; Hu WS; Mazurov D
    J Virol; 2015 Oct; 89(20):10591-601. PubMed ID: 26269177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds.
    Jung U; Takahashi M; Rossi JJ; Burnett JC
    Methods Mol Biol; 2016; 1354():255-64. PubMed ID: 26714717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus.
    Martins LJ; Bonczkowski P; Spivak AM; De Spiegelaere W; Novis CL; DePaula-Silva AB; Malatinkova E; Trypsteen W; Bosque A; Vanderkerckhove L; Planelles V
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):187-93. PubMed ID: 26171776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocytes impair efficacy of antiretroviral therapy.
    Couturier J; Winchester LC; Suliburk JW; Wilkerson GK; Podany AT; Agarwal N; Xuan Chua CY; Nehete PN; Nehete BP; Grattoni A; Sastry KJ; Fletcher CV; Lake JE; Balasubramanyam A; Lewis DE
    Antiviral Res; 2018 Jun; 154():140-148. PubMed ID: 29630975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1-mediated syncytium formation and virus replication by the lipophosphoglycan from Leishmania donovani is due to an effect on early events in the virus life cycle.
    Genois N; Barbeau B; Olivier M; Tremblay MJ
    Clin Exp Immunol; 2001 Apr; 124(1):32-42. PubMed ID: 11359440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.
    Steinkasserer A; Harrison R; Billich A; Hammerschmid F; Werner G; Wolff B; Peichl P; Palfi G; Schnitzel W; Mlynar E
    J Virol; 1995 Feb; 69(2):814-24. PubMed ID: 7815548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological consequences of early events following cell-cell contact between human immunodeficiency virus type 1-infected and uninfected CD4+ cells.
    Ruggiero E; Bona R; Muratori C; Federico M
    J Virol; 2008 Aug; 82(16):7773-89. PubMed ID: 18508887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.